The Centre of Research Excellence for the Study of Naevi was officially launched in April.
The innovative research program focuses on naevi (or moles) to advance understanding of melanoma and why some moles turn deadly while others never become a problem. Studies have consistently shown that the number of naevi is the strongest predictor of risk for melanoma. Many melanomas grow adjacent to or within pre-existing naevi, and melanocytic naevi are the major differential diagnosis of primary melanoma.
The collaborative project is led by Professor H. Peter Soyer from The University of Queensland’s Dermatology Research Centre. Professor Soyer says improved understanding of naevus development, transformation and recognition of changes is the key to understanding melanoma.“This would also help with establishing more efficient prevention and early detection models,” he said.
The project is funded by the Australian Government National Health and Medical Research Council (NHMRC) until the end of 2020. The research partners involved in the new CRE are:
- The University of Queensland (UQ)
- QIMR Berghofer Medical Research Institute
- Cancer Council Queensland (CCQ)
- The University of Sydney
- Queensland University of Technology (QUT)
Consumers will play an important role in the CRE to ensure the relevance of the research to the community and its translation into beneficial outcomes for people with melanoma. It is funded by the Australian Government National Health and Medical Research Council (NHMRC) until the end of 2020.
For further information, please visit the CRE for the Study of Naevi website.